Am J Psychiatry. 1985 Apr;142(4):469-76. doi: 10.1176/ajp.142.4.469.
This report represents the consensus of a panel of representatives from psychiatry, psychology, pharmacology, epidemiology, internal medicine, and the general public regarding the use of pharmacologic agents to prevent recurrences of mood disorders. The panel concluded that recurrent mood disorders, which have a high prevalence and serious consequences, are underdiagnosed and undertreated. Applying appropriate strategies to the management and use of pharmacologic agents will enhance the likelihood of compliance and the prevention of recurrence with a minimum of bothersome side effects. Such strategies should be used within the context of a supportive relationship among doctor, patient, and family.
本报告代表了来自精神病学、心理学、药理学、流行病学、内科医学领域的代表以及公众就使用药物预防情绪障碍复发问题所达成的共识。该小组得出结论认为，复发型情绪障碍患病率高且后果严重，目前存在诊断不足和治疗不足的情况。在药物管理和使用中应用适当策略，将提高依从性，并在将令人烦恼的副作用降至最低的情况下预防复发。这些策略应在医生、患者和家庭之间的支持性关系背景下使用。
